A novel oral peptide PN-477o with once-daily dosing, high potency and activation of glucagon-like peptide-1 (GLP-1), ...

The Shanghai-based biotech Renerval Therapeutics successfully completed the first clinical transfusion of platelets derived from induced pluripotent stem cells. The achievement has established the ...

Optiscan’s latest study is now underway, using its InVue and InForm devices to help surgeons assess breast cancer margins in ...

Sydney-based AI and medical technology company Echo IQ (ASX: EIQ) has announced the commencement of its clinical validation ...